血管內(nèi)皮生長(zhǎng)因子C(VEGFC)抗體對(duì)
Antibody Pair for Vascular Endothelial Growth Factor C (VEGFC)
VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein
- 編號(hào)PSA145Mu01
- 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
- 試劑內(nèi)容
血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白 50ug 標(biāo)準(zhǔn)品 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體 500ug 包被抗體 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)單克隆抗體(生物素標(biāo)記) 200ug 檢測(cè)抗體 - 應(yīng)用ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
- 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格96T*596T*1096T*2096T*5096T*100
- 價(jià)格¥ 5832 ¥ 9720¥ 17496¥ 34020¥ 58320
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
配對(duì)實(shí)驗(yàn)
用法
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma[PubMed: 19241443] |
genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages[PubMed: 26125824] |
Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia[PubMed: 26622498] |
Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages[PubMed: 26608451] |
PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.[pubmed:27383632] |
Oncology?Letters | RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo.[pubmed:27895746] |
Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering[Pubmed:29582235] |
Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells[Pubmed:29328465] |
LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease[Pubmed: 31019289] |
Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions?[Pubmed: 32722957] |